UNC-103 is a voltage-gated potassium channel homologous to mammalian ERG channels. Antibodies against UNC-103 are primarily used to:
Detect protein expression levels in tissues
Study subcellular localization
Investigate interactions with regulatory proteins like chaperones .
These antibodies have been instrumental in elucidating UNC-103’s role in neuromuscular regulation and behavior .
Key antibodies and their experimental uses include:
Egg-laying defects: unc-103 loss-of-function mutants exhibit premature egg-laying due to hyperexcitable vulval muscles .
Mating behavior: UNC-103 ensures proper timing of spicule protraction during mating by regulating protractor muscle contractions .
Locomotion: Thrashing assays revealed that UNC-103 gain-of-function mutations reduce muscle excitation, while loss-of-function increases it .
Chaperone dependency: The ER-localized chaperone CNX-1 (Calnexin homolog) is essential for UNC-103 protein stability. cnx-1 mutants show reduced UNC-103 levels and suppressed hyperexcitability phenotypes .
Isoform diversity: Alternative promoters and splicing generate UNC-103 variants with distinct N- and C-termini, enabling tissue-specific regulation .
Electrophysiological assays: UNC-103 channels exhibit delayed rectifier properties, and mutations (e.g., A334T) alter activation kinetics, mimicking human ERG channelopathies .
Sample preparation: Worms or transfected HEK293T cells are lysed in NP-40 buffer, followed by SDS-PAGE .
Antibodies used: Anti-GFP (1:1,000), anti-HA (1:500), and anti-β-Tubulin (loading control) .
UNC-103 antibodies have clarified the channel’s role in:
Neuromuscular coordination
Behavioral plasticity
Future studies could explore UNC-103’s interaction with L-type calcium channels or its potential as a drug target for channelopathies .